When and whether to conduct endocrine therapy in non-metastatic prostate cancer

Share :
Published: 27 Feb 2015
Views: 3095
Rating:
Save
Dr Frederik Birkebæk Thomsen - University of Copenhagen, Copenhagen, Denmark

Dr Thomsen talks to ecancertv at ASCO GU 2015 about his work looking at bicalutamide 150 mg daily versus placebo in hormone-naïve, non-metastatic prostate cancer.